FDA Advisory Panel Approves Onyx Blood Cancer Drug
Shares of Onyx Pharmaceuticals (ONXX) rocketed Thursday after the company reported that a Food and Drug Administration panel had approved Onyx's Kyprolis for patients with relapsed and refractory multiple myeloma who have received at least two prior lines of therapy. Onyx reported late Wednesday that the FDA's Oncologic Drugs Advisory Committee had approved the use of Kyprolis. The committee provides the FDA with independent expert advice and
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here